Latest filing published 05 Mar 2025 for Atara Biotherapeutics, Inc., €8,137.
Filing timeline
BuySaleInsider track record
Eric J. Hyllengren: trading record in brief
This profile gathers the share dealings of Eric J. Hyllengren in Atara Biotherapeutics, Inc. In total, 14 filings cover trades dated from 16 May 2023 to 3 March 2025.
On the market, this insider has only sold: 12 sales, €81k in total. Outside the open market, there are 2 share grants. Since January 2025: no purchases and 1 sale on the market.
Most recently, on 5 March 2025, the filings show an open-market sale worth €8,137 in Atara Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Eric J. Hyllengren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,211 shares@ US$6.99711.3% of flowCommon StockSEC:0000905148-25-000864:0
- 34,050 shares0Common StockSEC:0000905148-25-000245:0
- 1,364 shares@ US$11.19820.1% of flowCommon StockSEC:0000905148-24-003242:0
- 1,041 shares@ US$6.6298.7% of flowCommon StockSEC:0000905148-24-002303:0
- 29 shares@ US$6.6310.2% of flowCommon StockSEC:0000905148-24-002303:1
- 28,648 shares@ US$0.61722.6% of flowCommon StockSEC:0000905148-24-001558:0
- 1,462 shares@ US$0.7211.4% of flowCommon StockSEC:0000905148-24-000908:0
- 475,000 shares0Common StockSEC:0000905148-24-000112:0
- 11,958 shares@ US$0.3896.0% of flowCommon StockSEC:0000905148-23-001509:0
- 6,408 shares@ US$1.65213.5% of flowCommon StockSEC:0001140361-23-040564:0
- 6,199 shares@ US$2.03716.1% of flowCommon StockSEC:0001140361-23-025558:0
11 of 11 declarations
